NetScientific plc
("NetScientific" or the "Company")
Director/PDMR Shareholding
NetScientific Plc (AIM: NSCI), the investment and commercialisation group with an international portfolio of innovative life science, sustainability and industrial technology companies, announces that on 6 June 2023, Dr. Jonathan Robinson (Interim Non-Executive Chair and a Director of the Company) purchased shares in NetScientific Plc into his Self Invested Personal Pension.
Following the purchase, Dr. Jonathan Robinson now holds 174,253 shares, representing 0.74 Per cent. of the Company's issued share capital.
The following notification, made pursuant to Article 19(3) of the Market Abuse Regulation, provides further details.
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR PERSONS CLOSELY ASSOCIATED WITH THEM
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Dr. Jonathan Robinson | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| NetScientific plc | ||||
| b)
| LEI
| 213800N5WD46G1Y7I458 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of £0.05 each
GB00BN4R5Q82 | ||||
| b)
| Nature of the transaction
| Purchase of NSCI shares into SIPP | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
N/A
| ||||
| e)
| Date of the transaction
| 6 June 2023 | ||||
| f)
| Place of the transaction
| UK AIM | ||||
# # #
For more information, please contact:
| NetScientific | |
| Ilian Iliev, CEO | Via Belvedere Communications |
|
|
|
| WH Ireland (NOMAD, Financial Adviser and Broker) |
|
| Chris Fielding / Darshan Patel | +44 (0)20 7220 1666 |
| | |
| Belvedere Communications John West / Llew Angus |
+44 (0)20 3008 6867 |
About NetScientific
NetScientific plc (AIM: NSCI) is an investment and commercialisation group with an international portfolio of innovative life science, sustainability and technology companies.
NetScientific identifies, invests in, and builds high growth companies in the UK and internationally. The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.
NetScientific differentiates itself by employing a capital-light investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.
NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.